Drug Fix: Lessons From US FDA Commissioner Nominee Heidi Overton’s Confirmation Hearing

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs dissect US Food and Drug Administration commissioner nominee Heidi Overton’s answers during her Senate confirmation hearing and dominant themes (:58), rate the potential for her confirmation (13:14), as well as consider her responses to particular controversial issues like mifepristone safety (16:06) and more practical issues like advisory committee meetings (21:23). They also look at the remaining hurdles for Overton’s bid to take control of the agency (24:40).

More On These Topics From The Pink Sheet

Overton Calls MMR Vaccine ‘Not Lethal,’ Defends Trump’s Claim As Outreach To Vaccine Skeptics: insights.citeline.com/pink-sheet/agency-leader…

US FDA Commissioner Nominee Overton Says Adcomms ‘Critical,’ Hedges On Mifepristone Safety: insights.citeline.com/pink-sheet/agency-leader…

Former FDA Commissioners’ Backing May Help Overton Amid Stakeholder Opposition: insights.citeline.com/pink-sheet/agency-leader…